Search research articles
Contact Us
Filters
Showing results (241-250 of 254) with videos related to
Page
of 26
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 15, 2013
Locomotor sensitization to ethanol impairs NMDA receptor-dependent synaptic plasticity in the nucleus accumbens and increases ethanol self-administration
Karina Possa Abrahao, Olusegun J Ariwodola, Tracy R Butler, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Treatment continuation in patients receiving biological agents or conventional DMARD therapy
A Zink, J Listing, S Kary, et al.
Scandinavian Journal of Rheumatology
|
July 2, 2004
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate
R Rau, S Simianer, P L C M van Riel, et al.
Arthritis and Rheumatism
|
December 31, 1998
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
B Bresnihan, J M Alvaro-Gracia, M Cobby, et al.
JAMA Network Open
|
June 16, 2023
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
Koji Matsuo, Shinya Matsuzaki, Michihide Maeda, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2023
Alternative end-joining results in smaller deletions in heterochromatin relative to euchromatin
Jacob M Miller, Sydney Prange, Huanding Ji, et al.
Molecular Psychiatry
|
November 27, 2022
Ventral tegmental area glutamate neurons mediate nonassociative consequences of stress
Dillon J McGovern, Annie Ly, Koy L Ecton, et al.
Annals of the Rheumatic Diseases
|
August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
J A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Annals of the Rheumatic Diseases
|
December 3, 2003
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study
L B A van de Putte, R Rau, F C Breedveld, et al.
The Journal of Rheumatology
|
March 25, 1999
Imaging in rheumatoid arthritis: results of group discussions
E T Molenaar, M Boers, D M van der Heijde, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 254) with videos related to
Sort By:
Page
of 26
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 15, 2013
Locomotor sensitization to ethanol impairs NMDA receptor-dependent synaptic plasticity in the nucleus accumbens and increases ethanol self-administration
Karina Possa Abrahao, Olusegun J Ariwodola, Tracy R Butler, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Treatment continuation in patients receiving biological agents or conventional DMARD therapy
A Zink, J Listing, S Kary, et al.
Scandinavian Journal of Rheumatology
|
July 2, 2004
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate
R Rau, S Simianer, P L C M van Riel, et al.
Arthritis and Rheumatism
|
December 31, 1998
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
B Bresnihan, J M Alvaro-Gracia, M Cobby, et al.
JAMA Network Open
|
June 16, 2023
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
Koji Matsuo, Shinya Matsuzaki, Michihide Maeda, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2023
Alternative end-joining results in smaller deletions in heterochromatin relative to euchromatin
Jacob M Miller, Sydney Prange, Huanding Ji, et al.
Molecular Psychiatry
|
November 27, 2022
Ventral tegmental area glutamate neurons mediate nonassociative consequences of stress
Dillon J McGovern, Annie Ly, Koy L Ecton, et al.
Annals of the Rheumatic Diseases
|
August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
J A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Annals of the Rheumatic Diseases
|
December 3, 2003
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study
L B A van de Putte, R Rau, F C Breedveld, et al.
The Journal of Rheumatology
|
March 25, 1999
Imaging in rheumatoid arthritis: results of group discussions
E T Molenaar, M Boers, D M van der Heijde, et al.
Page
of 26